Article
Real-World Diagnostic Accuracy of Fully Autonomous, FDA-Approved Artificial Intelligence Systems for Diabetic Retinopathy Screening in the United States: A Systematic Review and Meta-Analysis
2026-08-04
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> : Fully autonomous, FDA-approved artificial intelligence (AI) systems for diabetic retinopathy (DR) screening—LumineticsCore (formerly IDx-DR) and EyeArt—demonstrated high sensitivity and specificity in pivotal regulatory trials. Performance in real-world United States clinical practice, outside controlled trial conditions, has not been comprehensively pooled....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a1abbc4d-99c6-58dd-8b05-8735b477cecf
- DOI
- 10.21203/rs.3.rs-10570689/v1
